capital

Latest news articles about capital

Hycroft Announces Closing of $60 Million Private Placement

HYMC

(NASDAQ:HYMC) WINNEMUCCA, Nev., Sept. 11, 2025 /PRNewswire/ -- Hycroft Mining Holding Corporation (Nasdaq: HYMC) ("Hycroft" or the "Company") is pleased to announce the closing of the non-brokered private placement (the "Private Placement") announced on September 2, 2025, with Eric Sprott as the lead...

September 11, 2025Read more →

SELLAS Life Sciences Group Announces Exercise of Existing Warrants Held by a Current Institutional Investor for $23.6 Million in Gross Proceeds

SLS

(NASDAQ:SLS) NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced the immediate exercise of warrants, previously issued in January 2025, to purchase up to 19,685,040 shares of its common stock for gross cash proceeds of approximately $23.6 million.

September 11, 2025Read more →

Cohen & Steers Infrastructure Fund, Inc. Announces Terms of Transferable Rights Offering

UTF

(NYSE:UTF) NEW YORK, Sept. 10, 2025 /PRNewswire/ -- Cohen & Steers Infrastructure Fund, Inc. (NYSE: UTF) (the "Fund") announced today that its Board of Directors has approved the terms of the issuance of transferable rights ("Rights") to the holders of the Fund's common stock (par value $0.001 per...

September 10, 2025Read more →

Mineralys Therapeutics Announces Closing of Upsized $287.5 Million Underwritten Public Offering of Common Stock Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

MLYS

(NASDAQ:MLYS) RADNOR, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, announced today the closing of its previously announced underwritten public offering of 11,274,509 shares of its common stock, which includes the exercise in full of the underwriters’ option to purchase up to 1,470,588 additional shares of its common stock, at a public offering price of $25.50 per share. The aggregate gross proceeds to Mineralys from the offering, before deducting underwriting discounts and commissions and other estimated offering expenses, were approximately $287.5 million. All of the securities sold in the offering were sold by Mineralys.

September 4, 2025Read more →

Hycroft Announces US$60 Million Non-brokered Private Placement Priced At-The-Market Under Nasdaq Rules

HYMC

(NASDAQ:HYMC) Silver Designated a Critical Mineral by the U.S. Government WINNEMUCCA, Nev., Sept. 2, 2025 /PRNewswire/ -- Hycroft Mining Holding Corporation (Nasdaq: HYMC) ("Hycroft" or the "Company") is pleased to announce a non-brokered private placement (the "Private Placement"), priced...

September 2, 2025Read more →

TGS ASA – New Share Capital Registered

TGS

(NYSE:TGS) Oslo, Norway (1 September 2025) - Reference is made to the stock exchange announcement by TGS ASA (OSE: TGS) (the "Company") on 11 August 2025 regarding vesting of Performance Stock Units (PSUs) and Restricted Stock Units (RSUs).

September 1, 2025Read more →

Notice on the cancellation of own shares

On 29 August 2025, after the registration of the new wording of the Articles of Association of INVL Baltic Real Estate (hereinafter - “the Company”) in the Register of Legal Entities, the procedure of the reduction of the authorized capital of the Company has ended. During this procedure, 107,480 units of ordinary registered shares (which made up 1.33% of all shares issued by the Company), acquired by the Company through the share redemption processes, were cancelled. Information about the reduction of the authorised capital was announced on 9 May 2025: Notice on the reduction of the authorised capital.

September 1, 2025Read more →

Total Voting Rights and Capital

Octopus Titan VCT plc

September 1, 2025Read more →

Total Voting Rights and Capital

Octopus Future Generations VCT plc

September 1, 2025Read more →

Total voting rights and Capital

ALC

(NYSE:ALC) Albion Crown VCT PLC

August 29, 2025Read more →

Total voting rights and Capital

Albion Enterprise VCT PLC

August 29, 2025Read more →

Total voting rights and Capital

Albion Technology & General VCT PLC

August 29, 2025Read more →

Southern Champion Tray® Unveils State-of-the-Art Heidelberg Boardmaster Press, Advancing Print Capabilities and Customer Experience

CHATTANOOGA, Tenn., Aug. 28, 2025 /PRNewswire/ -- Southern Champion Tray®, a leading manufacturer of sustainable paperboard packaging, proudly announces the installation of the new Heidelberg Boardmaster Flexographic Press at its Centre South facility. This strategic investment reinforces...

August 28, 2025Read more →

Credit Agricole Sa: 2025 CAPITAL INCREASE RESERVED FOR EMPLOYEES

ACA

Press release

August 28, 2025Read more →

Playboy Converts Remaining Preferred Shares to Common Stock at Over $1.74 Per Share

PLBY

Company Continues to Improve Balance Sheet Company Continues to Improve Balance Sheet

August 25, 2025Read more →

Galmed Announces Digital Asset Management Strategy to Enhance Capital Efficiency and Drive Shareholder Value

GLMD

An amendment to the Company's Articles of Association to increase the authorized share capital from 50,000,000 ordinary shares to 900,000,000 ordinary shares was approved at the Company's Special General Meeting of shareholders held on August 15, 2025 The Company is initially planning to...

August 25, 2025Read more →

Eloro Resources Announces Upsize of Bought Deal LIFE Private Placement for Gross Proceeds of C$10.0 Million

ELR

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES.

August 22, 2025Read more →

Information on shares, voting rights and authorized capital

After the authorised capital reduction on 20 August 2025, Artea Bankas AB (hereinafter - the Bank) pursuant to Article 19(2) of the Law on Securities of the Republic of Lithuania provides information on the total number of voting rights granted by the shares issued by it and the amount of the authorized capital, the number of shares and their nominal value:

August 20, 2025Read more →

Empire Petroleum Announces Extension of Previously Announced Rights Offering

EP

TULSA, Okla.--(BUSINESS WIRE)--Empire Petroleum Corporation (NYSE American: EP) ("Empire" or the "Company"), an oil and gas company with current producing assets in New Mexico, North Dakota, Montana, Texas, and Louisiana, announced today that it has extended the expiration date of its previously announced subscription rights offering (“Rights Offering”) pursuant to which it intends to raise gross proceeds of up to approximately $5.0 million, including $2.5 million from the exercise of the warra

August 19, 2025Read more →

American Lithium Closes Oversubscribed Private Placement

ALCO

Not for distribution to U.S. news wire services or dissemination in the United States

August 18, 2025Read more →